Preventing Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit using a Modified Ventilator-Associated Pneumonia Bundle: Pre-interventional and Post-interventional Trial
Keywords:
Ventilator-associated pneumonia, VAP prevention bundle, Modified pediatric VAP bundle, Pediatric Intensive Care UnitAbstract
Background: Ventilator-associated pneumonia increases in-hospital stay, morbidity and mortality of ventilated pediatric patients. It prolongs time spent on the ventilator and length of Pediatric Intensive Care Unit stay.
Methods: This is a pre-interventional and post-interventional trial of 57 and 50 pediatric patients, respectively, which started in March 2011 to decrease the rate of ventilator-associated pneumonia in Pediatric Intensive Care Unit after initiation of a modified pediatric VAP bundle compared with the ventilator-associated pneumonia rate for the preceding 12 months. The study was conducted at Makassed General Hospital in Beirut, Lebanon. It included pediatric patients that were on mechanical ventilation from March 2010 to March 2012. An interdisciplinary performance improvement team was formed, who implemented a modified pediatric VAP bundle.
Results: The implementation of the pediatric VAP bundle resulted in the reduction of ventilator-associated pneumonia rates from 52% (March 2010-2011) to 6% (March 2011-2012) (P<0.001).Patients who had VAP had longer stay on mechanical ventilation with a mean of 11.42 ventilator-days than those who didn’t develop ventilator-associated pneumonia with a mean of 5.18 ventilator-days (P<0.0001).
Conclusion: Implementing the modified pediatric VAP bundle significantly reduced the ventilator-associated pneumonia rate, time on mechanical ventilation and hospital length stay with potential decrease in cost.
References
1. Centers for Disease Control and Prevention. Criteria for defining nosocomial pneumonia Availa-bleat:http://www.cdc.gov/ncidod/hip/NNIS/members/pneumonia/final/PneuCriteriaFin-al.pdf. Accessed March 15, 2010.
2. Payne NR, Carpenter JH, Badger GJ, et al. Marginal in-crease in cost and excess length of stay associated with nosocomial blood stream infections in surviving very low birth weight infants. Pediatrics 2004; 114:3488–55.
3. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurode-velopmental and growth impairment among extremely low birth weight infants with neonatal infection. JAMA 2004; 292: 2357–65.
4. Van der Zwet WC, Kaiser AM, Van Elburg RM, et al. Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection spe-cifically adapted for neonates. J Hosp Infect 2005; 61:300–11.
5. Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996; 98:357–61.
6. Drews MB, Ludwig AC, Leititis JU, et al. Low birth weight and nosocomial infection of neonates in a neonatal intensive unit. J Hosp Infect 1995; 30:65-72.
7. Witaya Petdachaiet al. Ventilator-associated pneumonia in a newborn intensive care unit. Southeast Asian J Trop Med Public Health 2004; 35:724-9.
8. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Re-sults of the European Prevalence of Infection Care (EPIC) study. JAMA 1995; 274: 639-44.
9. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. 2002;J Pediatr140: 432-8
10. Institute for Healthcare Improvement. Getting started kit: prevent ventilator-associated pneumonia. How-to guide. 2008. Available at: http://www.premierinc.com/safety/topics/bundling/downloads/03-vap-how-to-guide.pdf Accessed January 3, 2009 (archived by WebCite® at http://www.webcitation.org/5e4ZDGYRY).
11. Youngquist P, Carroll M, Farber M, et al. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf2007; 33:219–225
12. Centers for Disease Control and Prevention (CDC). Guide-lines for prevention of healthcare-associated pneumonia. MMWR Recomm Rep 2004; 53:1–36.
13. American Thoracic Society Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416.
14. Kollef MH. Prevention of hospital-associated pneumonia and ventilator-Associated pneumonia. Crit Care Med 2004; 32:1396–405.
15. Resar R, Pronovost P, Haraden C, et al. Using a bundle approach to Improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005; 31(5):243–8.
16. Lorente L, Blot S, Rello J. Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J 2007; 30:1193–207.
17. Omrane R, Eid J, Perreault MM, et al. Impact of a proto-col for prevention of ventilator-associated pneumonia. Ann Pharmacother 2007; 41:1390–6.
18. Gastmeier P, Geffers C. Prevention of ventilator-associated pneumonia: analysis of studies published since 2004. J Hosp Infect 2007; 67:1–8.
19. Institute for Healthcare Improvement. Implement the ventilator bundle. Available
20. from:http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ImplementtheVentilatorBundle.htm.
21. Accessed October 11, 2009.
22. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8
23. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR. Nosocomial infection rates in US chil-dren’s hospitals’ neonatal and pediatric intensive care units. Am J Infect Control 2001; 29: 152-7.
24. Cordero L, Ayers LW, Miller RR, Seguin JH, Coley BD. Surveillance of ventilator-associated pneumonia in very-low-birth-weight infants. Am J InfectControl2002; 30: 32-9
25. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med1998; 129:433-40.
26. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics2002; 109: 758-64.
27. Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition inpa-tients receiving mechanical ventilation: multiple source of tracheal colonization include the stomach. Am J Med1986; 80: 827-32.
28. Craven DE, Barber TW, Steger KA, et al. Nosocomial pneumonia in the 1990s: update of epidemiology and risk factors. Semin Respir Infect 1990; 5: 157-72.
29. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
30. Niedermann M, Torres A, Summer W. Invasive diagnos-tic testing is not needed routinely to manage suspect ventilator-associated pneumonia. Am J Respir Crit Care Med1994; 150: 565-9.
31. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, etal. Im-pact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med 1998; 157: 371-6
32. Dorca J, Manresa F, Esteban L, et al. Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ul-trathin needle in non-ventilated nosocomial pneumonia. Am J Respir Crit Care Med1995; 151: 1491-6.
33. Papazian L, Bregenon F, Thirion X, et al. Effect of ventila-tor-associated pneumonia on mortality and morbidity. Am J RespirCritCare Med1996; 154:91-7
34. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug re-sistant bacteria. Am J Respir Crit Care Med1998; 157: 531-9
35. Waterer GW, Wunderink RG. Increasing threat of gram negative bacteria. Crit Care Med 2001; 29 (suppl): N75-81
36. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med1991; 91 (suppl 3B): S72-5
37. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States National Noso-comial Infections Surveillance System. Pediatrics 1996; 98: 357-61
38. Avila-Figueroa C, Goldman DA, Richardson DK, Gray JE, Ferrari AF, Freeman J. Intravenous lipid emulsions are the major determinant of coagulase negative staphylococ-cal bacteremia in very low birth weight newborns. Pedi-atr Infec Dis J 1998; 17: 10-7
39. Towner KJ. Clinical importance and antibiotic resistance of Acinetobacterspp. J Med Microbiol1997; 46: 721-46
40. Fagon JY, Chastre J, Vaugnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA1996; 275: 866-9
41. Cunha BA. Nosocomial pneumonia: diagnostic and thera-peutic considerations. Med Clin North Am2001; 85: 79-114
42. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med2001; 29: 1109-15
Downloads
Published
How to Cite
Issue
Section
License
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
